The table below shows Amneal Pharmaceuticals, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$26.74M
$7.41M
-$4.41M
$139.71M
$120.34M
$148.13M
Capital expenditure
$8.18M
$13.16M
$9.20M
$9.69M
$10.79M
$11.78M
Investing cash flow
-$21.71M
-$17.80M
-$19.76M
-$11.74M
-$97.39M
-$12.69M
Dividends paid
-
-
-
-
AMRX operating cash flow (10-K history)
Amneal Pharmaceuticals, Inc. reported operating cash flow of $339.99M for fiscal year 2025. That is up 15.2% from $295.10M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $115.06M (FY 2016) to $339.99M. Figures come from the company's audited annual reports as filed with the SEC.
